MURANO: Final 7 Year Follow Up and Retreatment Analysis in Venetoclax‐rituximab (venr)‐treated Patients with Relapsed/refractory Chronic Lymphocytic Leukemia (R/R CLL)
Hematological Oncology（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined